ENTACOVER 0.5 Entecavir IP (0.5mg) Entecavir IP (0.5mg) is a medication used to treat chronic hepatitis B virus (HBV) infection. It is an antiviral drug that belongs to the class of nucleoside analogue reverse transcriptase inhibitors (NRTIs). Entecavir helps reduce the replication and spread of the hepatitis B virus in the body, slowing down the progression of the disease and reducing the risk of liver damage. Here are some key points to know about Entecavir IP (0.5mg): Indication: Entecavir is prescribed to adults and sometimes pediatric patients (depending on their age and weight) with chronic hepatitis B infection. It is not a cure for hepatitis B but is used to control the virus and improve liver function. Dosage: The standard dose of Entecavir for adults is typically 0.5mg once daily. However, the exact dosage may vary based on the patient's individual medical history, the severity of the infection, and the doctor's recommendations. Mechanism of Action: Entecavir works by inhibiting the reverse transcriptase enzyme used by the hepatitis B virus to replicate its genetic material. By interfering with the virus's ability to reproduce, it helps lower the viral load in the body Monitoring: While taking Entecavir, patients may require regular monitoring of their liver function and viral load. This allows healthcare providers to assess the effectiveness of the treatment and make any necessary adjustments. Treatment Duration: The duration of Entecavir therapy can vary from person to person. Some individuals may need to take it long-term to control the virus effectively and prevent liver complications. Side Effects: Common side effects of Entecavir may include headache, fatigue, dizziness, and nausea. Serious side effects are rare but can include kidney problems, lactic acidosis, or worsening liver disease. It is crucial to report any unusual or severe side effects to a healthcare provider promptly. Resistance: Like other antiviral medications, hepatitis B virus can develop resistance to Entecavir over time. Regular monitoring and adherence to the prescribed dosage are essential to minimize the risk of resistance. Discontinuation: Discontinuing Entecavir without consulting a healthcare provider is not recommended, as it can lead to a flare-up of the hepatitis B virus. Your doctor will advise you on when and how to stop the medication safely Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/entacover-0-5-133926